Template:Atrial fibrillation: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(19 intermediate revisions by 9 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15%; text-align: left; font-size: 85%; background:AliceBlue"
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
 
'''Atrial Fibrillation Microchapters'''
'''Atrial fibrillation Microchapters
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
Line 23: Line 21:
!
!
[[Atrial fibrillation overview|Overview]]
[[Atrial fibrillation overview|Overview]]
|-
!
|- bgcolor="Pink"
!
[[Atrial fibrillation historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 84: Line 88:
: [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]]
: [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]]
: [[Atrial fibrillation pregnancy|Pregnancy]]
: [[Atrial fibrillation pregnancy|Pregnancy]]
: [[Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention|ACS and/or PCI or valve intervention]]
: [[Congestive heart failure treatment of patients who have concomitant disorders|Heart failure]]
|-  
|-  
!
!
Line 114: Line 120:
!
!
[[Atrial fibrillation electrocardiogram|Electrocardiogram]]
[[Atrial fibrillation electrocardiogram|Electrocardiogram]]
|-
!
|- bgcolor="LightSkyBlue"
!
:[[Atrial fibrillation EKG examples|EKG Examples]]
:[[Atrial fibrillation EKG examples|EKG Examples]]
:[[Atrial fibrillation with LBBB EKG examples|A-Fib with LBBB]]
:[[Atrial fibrillation with LBBB EKG examples|A-Fib with LBBB]]
Line 153: Line 154:
|-  
|-  
!
!
 
|- bgcolor="PaleTurquoise"
!
[[Atrial fibrillation rate control|Rate and Rhythm Control]]
|-
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Cardioversion
Cardioversion
:[[Atrial fibrillation cardioversion#Overview|Cardioversion Overview]]
:[[Atrial fibrillation cardioversion#Overview|Overview]]
:[[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]]
:[[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]]
:[[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]]
:[[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]]
Line 176: Line 181:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation rate control|Rate Control]]
[[Atrial fibrillation maintenance of rate control and sinus rhythm|Maintenance of Sinus Rhythm]]
|-  
|-  
!
!
Line 182: Line 187:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation maintenance of rate control and sinus rhythm|Maintenance of Sinus Rhythm]]
Surgery
: [[Atrial fibrillation catheter ablation|Catheter Ablation]]
: [[AV nodal ablation|AV Nodal Ablation]]
: [[Atrial fibrillation surgical ablation|Surgical Ablation]]
: [[Atrial fibrillation cardiac surgery|Cardiac Surgery]]
|-  
|-  
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation specific patient groups|Specific Patient Groups]]
|-
!


!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Surgery
[[Atrial fibrillation primary prevention|Primary Prevention]]
: [[Atrial fibrillation invasive treatment|Radiofrequency Ablation]]
: [[Atrial fibrillation surgical treatment|Maze Open Heart Surgery]]
|-  
|-  
!
 


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
Line 198: Line 211:
[[Atrial fibrillation secondary prevention|Secondary Prevention]]
[[Atrial fibrillation secondary prevention|Secondary Prevention]]
|-  
|-  
!
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation supportive trial data|Supportive Trial Data]]
|-
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Atrial fibrillation clinical trial data|Supportive Trial Data]]
[[Atrial fibrillation cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  

Latest revision as of 16:01, 22 July 2021

Atrial Fibrillation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups

Postoperative AF
Acute Myocardial Infarction
Wolff-Parkinson-White Preexcitation Syndrome
Hypertrophic Cardiomyopathy
Hyperthyroidism
Pulmonary Diseases
Pregnancy
ACS and/or PCI or valve intervention
Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples
A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion

Overview
Electrical Cardioversion
Pharmacological Cardioversion

Anticoagulation

Overview
Warfarin
Converting from or to Warfarin
Converting from or to Parenteral Anticoagulants
Dabigatran

Maintenance of Sinus Rhythm

Surgery

Catheter Ablation
AV Nodal Ablation
Surgical Ablation
Cardiac Surgery

Specific Patient Groups

Primary Prevention

Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation

CDC on Atrial fibrillation

Atrial fibrillation in the news

Blogs on Atrial fibrillation

Directions to Hospitals Treating Atrial fibrillation

Risk calculators and risk factors for Atrial fibrillation